HERON THERAPEUTICS financial statements, including revenue, expenses, profit, and loss

The total revenue of AXD2 for the last quarter is 31.28 M CHF, and it's 8.52% higher compared to the previous quarter. The net income of Q1 24 is -2.85 M CHF.